Mentioned On
Episode Mentions
BioSpace · May 13, 2026
Makary’s out at FDA, Sanofi’s priority voucher issues, top exec pay
“COVID-19 vaccine review involved controversial FDA intervention by Sarah Brenner in 2024”
FDA Commissioner leadership transition and removalRegulatory uncertainty and HHS agency turnoverCommissioner's National Priority Review voucher program
View AnalysisThis Week in Virology · Feb 7, 2026
TWiV 1294: Clinical update with Dr. Daniel Griffin
“Protein-based COVID-19 vaccine approved for ages 12 and older, alternative to mRNA vaccines”
Measles outbreak response and clinical recognitionPediatric COVID-19 vaccination strategiesLong COVID prevention and treatment
View AnalysisLeaked · Jan 27, 2026
Redfield on Risk: Gain-of-Function, Bird Flu, and the Next Pandemic
“Protein vaccine manufacturer; recommended by Redfield as safer alternative to mRNA vaccines for vulnerable populations”
COVID-19 Lab Origin Theory and Wuhan Institute of VirologyGain-of-Function Research Regulation and EnforcementmRNA Vaccine Safety and Adverse Events
View Analysis